Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Other financing activities (2016 - 2024)

Insmed's Other financing activities history spans 8 years, with the latest figure at $3.7 million for Q4 2024.

  • Quarterly Other financing activities changed N/A to $3.7 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Mar 2025, up 713.69% year-over-year, with the annual reading at $3.7 million for FY2024, 206.81% up from the prior year.
  • Other financing activities came in at $3.7 million for Q4 2024, up from -$409000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $17.8 million in Q4 2022 to a low of -$936000.0 in Q4 2020.
  • The 5-year median for Other financing activities is $212500.0 (2021), against an average of $2.7 million.
  • Year-over-year, Other financing activities skyrocketed 111043.75% in 2022 and then plummeted 66.42% in 2024.
  • Insmed's Other financing activities stood at -$936000.0 in 2020, then soared by 101.71% to $16000.0 in 2021, then surged by 111043.75% to $17.8 million in 2022, then plummeted by 93.15% to $1.2 million in 2023, then soared by 206.81% to $3.7 million in 2024.
  • Per Business Quant, the three most recent readings for INSM's Other financing activities are $3.7 million (Q4 2024), -$409000.0 (Q2 2024), and $409000.0 (Q1 2024).